These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 35469984)
1. COVID-19 inflammation and implications in drug delivery. Zoulikha M; Huang F; Wu Z; He W J Control Release; 2022 Jun; 346():260-274. PubMed ID: 35469984 [TBL] [Abstract][Full Text] [Related]
2. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review. Yarmohammadi A; Yarmohammadi M; Fakhri S; Khan H Eur J Pharmacol; 2021 Jan; 890():173620. PubMed ID: 33038418 [TBL] [Abstract][Full Text] [Related]
3. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Amere Subbarao S Inflammopharmacology; 2021 Apr; 29(2):343-366. PubMed ID: 33723711 [TBL] [Abstract][Full Text] [Related]
7. Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19. Tan Q; He L; Meng X; Wang W; Pan H; Yin W; Zhu T; Huang X; Shan H J Nanobiotechnology; 2021 Jun; 19(1):173. PubMed ID: 34112203 [TBL] [Abstract][Full Text] [Related]
8. Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? Giovinazzo G; Gerardi C; Uberti-Foppa C; Lopalco L Molecules; 2020 Dec; 25(24):. PubMed ID: 33322757 [TBL] [Abstract][Full Text] [Related]
9. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19. Mostafa-Hedeab G; Al-Kuraishy HM; Al-Gareeb AI; Jeandet P; Saad HM; Batiha GE Inflammopharmacology; 2022 Jun; 30(3):799-809. PubMed ID: 35486310 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory response of cardamom extract and prediction of therapeutic window in COVID-19 patients by assessing inflammatory markers using RT-PCR. Shakeeb N; Varkey P; Hynse A; Mandlecha A Inflammopharmacology; 2022 Jun; 30(3):883-894. PubMed ID: 35320494 [TBL] [Abstract][Full Text] [Related]
11. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19. Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE Front Immunol; 2021; 12():749291. PubMed ID: 34867978 [TBL] [Abstract][Full Text] [Related]
12. CB2 receptor-selective agonists as candidates for targeting infection, inflammation, and immunity in SARS-CoV-2 infections. Nagoor Meeran MF; Sharma C; Goyal SN; Kumar S; Ojha S Drug Dev Res; 2021 Feb; 82(1):7-11. PubMed ID: 33190277 [TBL] [Abstract][Full Text] [Related]
13. Ursolic acid and SARS-CoV-2 infection: a new horizon and perspective. Al-Kuraishy HM; Al-Gareeb AI; Negm WA; Alexiou A; Batiha GE Inflammopharmacology; 2022 Oct; 30(5):1493-1501. PubMed ID: 35922738 [TBL] [Abstract][Full Text] [Related]
14. Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation. Cardone M; Yano M; Rosenberg AS; Puig M Front Immunol; 2020; 11():1131. PubMed ID: 32574265 [TBL] [Abstract][Full Text] [Related]
15. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review. Quirch M; Lee J; Rehman S J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537 [TBL] [Abstract][Full Text] [Related]
16. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications. Shawki MA; Elsayed NS; Mantawy EM; Said RS Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871 [TBL] [Abstract][Full Text] [Related]
17. Target-Specific Drug Discovery of Natural Products against SARS-CoV-2 Life Cycle and Cytokine Storm in COVID-19. Lee M; Park J; Cho IH Am J Chin Med; 2022; 50(4):927-959. PubMed ID: 35729089 [TBL] [Abstract][Full Text] [Related]
18. Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment. Zhao Z; Xiao Y; Xu L; Liu Y; Jiang G; Wang W; Li B; Zhu T; Tan Q; Tang L; Zhou H; Huang X; Shan H ACS Appl Mater Interfaces; 2021 May; 13(18):20995-21006. PubMed ID: 33930273 [TBL] [Abstract][Full Text] [Related]
19. The MEK1/2-inhibitor ATR-002 efficiently blocks SARS-CoV-2 propagation and alleviates pro-inflammatory cytokine/chemokine responses. Schreiber A; Viemann D; Schöning J; Schloer S; Mecate Zambrano A; Brunotte L; Faist A; Schöfbänker M; Hrincius E; Hoffmann H; Hoffmann M; Pöhlmann S; Rescher U; Planz O; Ludwig S Cell Mol Life Sci; 2022 Jan; 79(1):65. PubMed ID: 35013790 [TBL] [Abstract][Full Text] [Related]
20. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis. Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]